A modeling framework for evaluation and comparison of trigger strategies for switching from minipool to individual‐donation testing for West Nile virus
暂无分享,去创建一个
[1] R. Lanciotti,et al. Virus and antibody dynamics in acute west nile virus infection. , 2008, The Journal of infectious diseases.
[2] West Nile virus activity--United States, 2006. , 2007, MMWR. Morbidity and mortality weekly report.
[3] West Nile virus transmission through blood transfusion--South Dakota, 2006. , 2007, MMWR. Morbidity and mortality weekly report.
[4] Peter Tomasulo,et al. Screening the blood supply for West Nile virus RNA by nucleic acid amplification testing. , 2005, The New England journal of medicine.
[5] G. Foster,et al. West Nile Virus Among Blood Donors in the United States, 2003 and 2004 , 2005, The New England journal of medicine.
[6] M. Drebot,et al. Analytical and clinical sensitivity of West Nile virus RNA screening and supplemental assays available in 2003 , 2005, Transfusion.
[7] P. Tomasulo,et al. Triggers for switching from minipool testing by nucleic acid technology to individual‐donation nucleic acid testing for West Nile virus: Analysis of 2003 data to inform 2004 decision making , 2004, Transfusion.
[8] R. Lanciotti,et al. Transmission of West Nile virus through blood transfusion in the United States in 2002. , 2003, The New England journal of medicine.
[9] B. Biggerstaff,et al. Estimated risk of transmission of the West Nile virus through blood transfusion in the US, 2002 , 2003, Transfusion.